Straumann Holding AG (XSWX:STMN) 3-1 Month Momentum %: 11.81% (As of Jul. 12, 2026)


XSWX:STMN Straumann Holding AG XSWX:STMN
100 GF Score
Price CHF105.20
GF Value CHF137.45
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Straumann Holding AG 3-1 Month Momentum %?

Straumann Holding AG XSWX:STMN +1.50% 100 3-1 Month Momentum % is 11.81% as of Jul. 12, 2026. GuruFocus rates XSWX:STMN with a GF Score™ of 100/100 and a GF Value™ of CHF137.45 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 849 Medical Devices & Instruments companies, Straumann Holding AG ranks better than 82.57% on this metric.

3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-07-12), Straumann Holding AG's 3-1 Month Momentum % is 11.81%.

The industry rank for Straumann Holding AG's 3-1 Month Momentum % or its related term are showing as below:

XSWX:STMN's 3-1 Month Momentum % is ranked better than
82.57% of 849 companies
in the Medical Devices & Instruments industry
Industry Median: -6.91 vs XSWX:STMN: 11.81

Straumann Holding AG  (XSWX:STMN) 3-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Straumann Holding AG 3-1 Month Momentum % Related Terms


XSWX:STMN vs ISRG, BDX, MDLN: 3-1 Month Momentum % Comparison

For the Medical Instruments & Supplies subindustry, Straumann Holding AG's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Straumann Holding AG 3-1 Month Momentum % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Straumann Holding AG's 3-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Straumann Holding AG's 3-1 Month Momentum % falls into.


XSWX:STMN
100GF Score
Straumann Holding AG XSWX:STMN
3-1 Month Momentum % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Straumann Holding AG  (XSWX:STMN) 3-1 Month Momentum % Calculation

3-1 Month Momentum % is calculated as following:

3-1 Month Momentum %=( Price 1-month ago / Price 3-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 3-1 Month Momentum % →
What does a 3-1 Month Momentum % of 11.81% mean?
Straumann Holding AG (XSWX:STMN) has a 3-1 Month Momentum % of 11.81% as of Jul. 12, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Straumann Holding AG and its competitors. According to the industry distribution chart, Straumann Holding AG ranks #148 out of 849 companies in the Medical Devices & Instruments industry, placing it in the top 17.4%.
Is Straumann Holding AG's 3-1 Month Momentum % too high?
Straumann Holding AG's current 3-1 Month Momentum % is 11.81%. Based on the distribution chart, Straumann Holding AG ranks #148 out of 849 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Straumann Holding AG has a GF Score™ of 100/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Straumann Holding AG's 3-1 Month Momentum % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Straumann Holding AG ranks #148 out of 849 companies for 3-1 Month Momentum %. This places Straumann Holding AG in the top 17% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Medical Devices & Instruments company?
A good 3-1 Month Momentum % depends on the Medical Devices & Instruments industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Straumann Holding AG and its competitors. Straumann Holding AG's current 3-1 Month Momentum % is 11.81%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Straumann Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Straumann Holding AG (XSWX:STMN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF137.45, compared to a current price of CHF105.20 — trading 23.5% below its estimated fair value. The current 3-1 Month Momentum % is 11.81%. Straumann Holding AG's overall GF Score™ is 100/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Straumann Holding AG (XSWX:STMN), the current 3-1 Month Momentum % is 11.81% as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Straumann Holding AG (XSWX:STMN) Overvalued in 2026?

Based on GuruFocus' analysis, Straumann Holding AG stock appears to be undervalued. The current stock price of CHF105.20 is trading 23.5% below its estimated GF Value™ of CHF137.45. GuruFocus considers Straumann Holding AG to be Modestly Undervalued.

Key valuation signals for XSWX:STMN:

  • 3-1 Month Momentum %: 11.81%
  • GF Value™: CHF137.45 vs. price of CHF105.20 (23.5% below fair value)
  • GF Score™: 100/100 with 7 warning signs

No single metric tells the full story. See the XSWX:STMN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Straumann Holding AG Business Description

Address Peter Merian-Weg 12, Basel, CHE, 4002
Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The firm's core products are dental implants, and it holds over one third of the CHF 6 billion global market. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.
100GF Score

Get the complete analysis for XSWX:STMN

3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF105.20
Price
CHF137.45
GF Value